Navigation Links
Succeeding in Global Strategic Marketing for Strong Oncology Launches
Date:8/15/2014

CHAPEL HILL, N.C., Aug. 15, 2014 /PRNewswire/ -- Managing all the aspects of successfully launching a new oncology product is a daunting endeavor that often falls to the Global Strategic Marketing (GSM) function. As the oncology market continues to be a rapid growth area for the biopharmaceutical industry, leaders must continually assess their budgets, investment strategies, staffing, structure and scope of services.

According to recent research Global Strategic Marketing organizations are shifting their budgets to better fit their current needs. Budget increases are anticipated by as much as 73% of benchmark participants for activities supporting the Oncology pipeline. Few participants project any decreases in their budgets for this area.

The related report, "Oncology Global Strategic Marketing: Benchmarking Budget Levels & Service Scope," will help GSM leaders in oncology to better evaluate and improve their global strategic marketing programs. The study will allow leaders to understand the investment levels, marketing activities, timing, and structures needed to successfully steer products and pipeline programs through the complex oncology marketplace.

The 75-page study provides current benchmarks, such as:

  • GSM staffing benchmarks by role, by development phase, by number of oncology programs and per $100M in oncology sales
  • Outsourced and in-house labor dedicated to traditional and emerging markets
  • GSM organizational structure
  • Role of the GSM function for activities such as market intelligence, marketing, advocacy and KOL management
  • Spending benchmarks around key GSM activities within marketing, market intelligence and advocacy
  • Oncology GSM spending by phase of clinical development  

The study engaged GSM leaders supporting Oncology organizations at 17 companies. The study included both large, established and small, emerging Oncology companies to provide the broadest insights. Data is presented for large and emerging company segments throughout the report.  

To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1307.htm

For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Contraceptives Market 2014-2018: Key Vendors are Actavis, Bayer, Johnson & Johnsons, Janssen, Merck & Co, Pfizer and Teva
2. Global Regenerative Medicine (Stem Cell Therapy, Biomaterial and Tissue Engineering) Market (Bone and Joint) - Forecast to 2019
3. Western Blotting Instruments (Manual/Semi-automated/Automated) Market - Global Forecast to 2018
4. Kalorama Report: Acquisitions Driving Global Medical Device Market
5. Global and Chinese Diabetes Drugs Industry Report 2014
6. GenSpera to Present at Rodman & Renshaw 16th Annual Global Investment Conference
7. Ablation Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
8. Synergy Health plc Invests 18 Million GBP (US$30 Million) To Expand Global Applied Sterilisation Technology Capacity
9. Global Non-melanoma Skin Cancer Market 2014-2018
10. Global Hospital Information Systems (HIS) Market 2014-2018: Key vendors dominating this space are Cerner, Epic, McKesson and Siemens
11. Orthopedic Trauma Fixation Devices Market - Global Forecast to 2020
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Surgical Procedure Volumes: Global Analysis (United States, ... Australia, Canada)" report to their offering. ... an essential tool for healthcare business planners, provides surgical ... looks at surgery trends with an in-depth analysis of ...
(Date:6/23/2016)... , June 23, 2016 ... but it continues to present great opportunities to investors. ... for today: Intrexon Corp. (NYSE: XON ), ... Pharmaceuticals Inc. (NASDAQ: ARNA ), and Regeneron ... about these stocks and receive your complimentary trade alerts ...
(Date:6/23/2016)... 23, 2016 Leading BioSciences Inc., a ... conditions resulting from a breakdown of the mucosal ... Greg Doyle as chief executive officer. Mr. ... management team and board of directors, previously served ... He will provide continued leadership and strategic direction ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
Breaking Medicine News(10 mins):